CDH2 and nasopharyngeal carcinoma: β-catenin can activate multiple downstream growth signalling components, such as cyclin D1 and c-Myc, and interact with interleukin-8 (IL-8), RASSF1, E-cadherin, and N-cadherin, thereby leading to NPC carcinogenesis [164].